Haoxi Health Technology Limited - Class A Ord SharevsMeta Platforms

HAO and META stock compared: price, dividend, valuation and results, from SEC filings.

Over the last year, with dividends, HAO moved -99.9% and META +3.1%. Dividend yield: HAO none, META 0.34%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    HAO–

    META$1.58T

  • Revenue, 12 months

    HAO$55M

    META$242B

    META is 4,407 times HAO

  • Net income, 12 months

    HAO-$9.5M

    META$75.2B

  • Operating margin

    HAO-17.6%

    META32.9%

    50.5 points apart

  • ROIC

    HAO-42.1%

    META20.9%

    63.0 points apart

  • P/E

    HAO–

    META21.0

  • Dividend yield

    HAO0.0%

    META0.3%

    0.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

HAO-99.9%

META+3.1%

0100DecFebAprJunAugOct
Returns by period
PeriodHAOWith dividendsMETAWith dividends
1 year since November 14, 2025-99.9%Price -99.9%+3.1%Price +2.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

HAOHaoxi Health Technology Limited - Class A Ord ShareMETAMeta Platforms

Valuation

HAOMETA
Valuation
Price$2.00$626.41
Market value–$1.58T
Enterprise value (EV)–$1.58T
P/E–21.0
P/E, 5-year median–24.4
P/B–5.8
EV/EBIT–19.9
Free cash flow yield–1.8%

Results and growth

HAOMETA
Results and growth
Revenue, 12 months$55M$242B
Net income, 12 months-$9.5M$75.2B
Free cash flow, 12 months–$28.6B
Earnings per share, 12 months-$386.40$29.32
Revenue growth, year on year67.1%22.2%
Revenue growth a year, past+35.7%over 4 years+18.5%over 5 years
EPS growth a year, past–+18.4%over 5 years

Margins and returns on capital

HAOMETA
Margins and returns on capital
Gross margin1.2%81.0%
Operating margin-17.6%32.9%
Net margin-17.4%31.2%
ROIC-42.1%20.9%
ROE-53.4%31.7%

Balance sheet

HAOMETA
Balance sheet
Cash$11M$82.4B
Total debt$1.3M$115B
Net debt / EBITDA–0.0
Interest cover-184.3×30.6×

Dividends and buybacks

HAOMETA
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$2.10
Dividend growth a year, past––
Buyback yield–1.7%
Shareholder yield–2.0%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: HAO or META

Didn't find what you were looking for?

Ask us
How did HAO and META stock do over the last 1 years?

Since November 14, 2025, HAO's price moved -99.9% and META's +2.8%. With dividends: HAO -99.9% (-99.9% a year), META +3.1% (+3.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, HAO or META?

The dividend yield at today's price is none for Haoxi Health Technology Limited - Class A Ord Share and 0.34% for Meta Platforms. Over the last twelve months they paid – and $2.10 per share.

Which has the higher profit margins, Haoxi Health Technology Limited - Class A Ord Share or Meta Platforms?

Over the last twelve months, the net margin was -17.4% for Haoxi Health Technology Limited - Class A Ord Share and 31.2% for Meta Platforms, and the operating margin -17.6% and 32.9%. Revenue was $55M and $242B.

Which is the better investment, Haoxi Health Technology Limited - Class A Ord Share or Meta Platforms?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.